Incyte to Report Third Quarter Financial Results

WILMINGTON, Del.--()--Incyte Corporation (Nasdaq: INCY) announced today that it has scheduled its third quarter 2016 financial results conference call and webcast for 10:00 a.m. ET on Tuesday, November 1, 2016.

The schedule for the press release and conference call/webcast is as follows:

 

 

Q3 2016 Press Release:

  November 1, 2016 at 7:00 a.m. ET

Q3 2016 Conference Call:

November 1, 2016 at 10:00 a.m. ET

Domestic Dial-In Number:

877-407-9221

International Dial-In Number:

201-689-8597

Conference ID Number:

13647886

If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and the dial-in number for international callers is 201-612-7415. To access the replay you will need the conference ID number 13647886.

The live webcast with slides can be accessed at www.incyte.com under Investor Relations, Events and Webcasts and will be available for replay for 30 days.

About Incyte

Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit the Company's web site at www.incyte.com.

Follow @Incyte on Twitter at https://twitter.com/Incyte.

Contacts

Incyte Corporation
Investors
Michael Booth, DPhil, +1 302 498 5914
mbooth@incyte.com
or
Media
Catalina Loveman, +1 302 498 6171
cloveman@incyte.com

Contacts

Incyte Corporation
Investors
Michael Booth, DPhil, +1 302 498 5914
mbooth@incyte.com
or
Media
Catalina Loveman, +1 302 498 6171
cloveman@incyte.com